|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.510 USD | -5.65% |
|
-2.45% | - |
| Market Cap | 12.66M 10.95M 10.23M 9.38M 17.65M 1.21B 17.93M 120M 47.1M 604M 47.55M 46.51M 2B | P/E 2026 * |
23.3x | P/E 2027 * | 3.33x |
|---|---|---|---|---|---|
| Enterprise Value | 12.66M 10.95M 10.23M 9.38M 17.65M 1.21B 17.93M 120M 47.1M 604M 47.55M 46.51M 2B | EV / Sales 2026 * |
0.15x | EV / Sales 2027 * | 0.11x |
| Free-Float |
63.51% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -5.65% |
| Manager | Title | Age | Since |
|---|---|---|---|
Grigorios Siokas
CEO | Chief Executive Officer | 60 | 26/02/2016 |
Georgios Terzis
DFI | Director of Finance/CFO | 43 | 11/11/2020 |
| Chief Operating Officer | 56 | 01/02/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 58 | 13/01/2014 | |
Grigorios Siokas
CHM | Chairman | 60 | 26/02/2016 |
John Hoidas
BRD | Director/Board Member | 59 | 18/11/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.65% | -2.45% | - | - | 12.66M | ||
| -0.21% | +1.56% | +30.06% | +103.01% | 101B | ||
| -0.53% | +2.77% | +50.18% | +157.04% | 55.37B | ||
| -0.67% | -0.34% | +4.59% | +270.00% | 24.21B | ||
| +1.64% | -0.95% | -12.47% | -14.01% | 8.29B | ||
| +4.21% | -0.41% | -31.74% | -28.05% | 7.53B | ||
| +0.59% | -2.29% | -9.93% | -21.74% | 6.75B | ||
| +0.34% | +3.42% | +19.47% | +15.38% | 6.19B | ||
| -0.55% | -3.43% | -4.67% | +20.61% | 5.07B | ||
| +0.81% | -3.11% | -6.73% | -7.85% | 3.69B | ||
| Average | -0.00% | -0.35% | +4.31% | +54.93% | 24.28B | |
| Weighted average by Cap. | -0.07% | +1.38% | +25.63% | +116.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 84.3M 72.92M 68.1M 62.47M 117M 8.02B 119M 799M 314M 4.02B 317M 310M 13.29B | 111M 95.84M 89.5M 82.11M 154M 10.55B 157M 1.05B 412M 5.29B 416M 407M 17.47B |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COSM Stock
- COSM Stock
Select your edition
All financial news and data tailored to specific country editions
















